ETC
-
Lasix Inj.
- Ingredient
Furosemide
- Content
20mg/2ml
- Indication
1) Management of edema associated with heart failure (i.e. congestive heart failure), cirrhosis of the liver (i.e. ascites), or renal disease; acute pulmonary edema
2) Management of essential or renal hypertension
-
Lasix Tab.
- Ingredient
Furosemide
- Content
40mg
- Indication
Treatment of essential or renal hypertension; cardiac (congestive heart failure), renal, hepatic (ascites) and peripheral vascular edema
-
Megarozet Tab.
- Ingredient
Ezetimibe/Rosuvastatin Calcium
- Content
10/5mg, 10/10mg, 10/20mg
- Indication
Treatment of primary hypercholesterolemia: As an adjunct to diet for the reduction of elevated total-C, LDL-C, apolipoprotein-B (apo-B), triglycerides, and non-high-density lipoprotein cholesterol (HDL-C), and to increase HDL-C in patients with primary (heterozygous familial and nonfamilial) hyperlipidemia or mixed hypercholesterolemia
-
Munobal Tab.
- Ingredient
Felodipine
- Content
2.5mg, 5mg
- Indication
Treatment of hypertension, stable angina pectoris.
-
Opsumit 10mg Tab.
- Ingredient
Micronized Macitentan
- Content
10mg
- Indication
Long-term treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III.
-Effectiveness was established in patients with idiopathic and heritable PAH, PAH caused by connective tissue disorders, and PAH caused by congenital heart disease.
-
Paxerontine SR Tab. 12.5mg
- Ingredient
Paroxetine Hydrochloride
- Content
12.5mg
- Indication
1) Treatment of major depressive disorder
2) Treatment of panic disorder, with or without agoraphobia
3) Treatment of social anxiety disorder, also known as social phobia
4) Treatment of premenstrual dysphoric disorder (PMDD)
-
Paxerontine SR Tab. 25mg
- Ingredient
Paroxetine Hydrochloride
- Content
25mg
- Indication
1) Treatment of major depressive disorder
2) Treatment of panic disorder, with or without agoraphobia.
3) Treatment of social anxiety disorder, also known as social phobia.
4) Treatment of premenstrual dysphoric disorder (PMDD).
-
Relefact LH-RH
- Ingredient
Gonadorelin Acetate
- Content
0.1mg/1ml (as gonadorelin)
- Indication
1) Differential diagnosis of infertility
– Delayed puberty
– Primary sexual dysfunction as follows: Klinefelter’s syndrome, Turner’s syndrome and Sertoli-Cells-only syndrome.
– Secondary sexual dysfunction, such as: Kallmann’s syndrome, idiopathic eunuchoidism and Pasqualini’s syndrome
– Primary amenorrhea
– Secondary amenorrhea as in anorexia nervosa
2) Investigation of the location and severity of diseases occurring in the hypothalamic and pituitary gland
-
Roxan Cap.
- Ingredient
Roxatidine Acetate Hydrochloride
- Content
75mg
- Indication
– gastric and duodenal ulcer
– reflux esophagitis
– Zollinger-Ellison syndrome
– Pre-anesthesia in patients at risk of aspiration of stomach acid (Mendelson’s syndrome), especially pre-anesthesia in delivery
– Improvement of gastric mucosal lesions (erosion, hemorrhage, redness, edema) of the following diseases: acute exacerbation in acute or chronic gastritis
-
Rulid Pediatric Dispersed Tab. 50mg
- Ingredient
Roxithromycin Coated
- Content
Roxithromycin Coated 77mg (50mg as Roxithromycin)
- Indication
Effective Species: Streptococcus, Streptococcus pneumonia, Neisseria meningitidis, Neisseria gonorrhoeae, Bordetella pertussis, bacteria cocci associated with catarrh, Corynebacterium diphtheria, Clostridium perfringens, Mycoplasma pneumonia, Chlamydia trachomatis, Ureaplasma urealyticum, Legionella pneumophila, Campylobacter pylori, Campylobacter jejuni, Gardnerella vaginalis, Haemophilus influenza, Staphylococcus aureus, Vibrio cholera, and Chlamydia psittaci
Indications:
– respiratory infectious disease: pharyngolaryngitis, acute bronchitis, tonsillitis, bacterial pneumonia, mycoplasma pneumonia, etc.
– genital infections and sexually transmitted diseases, excluding infection by Neisseria gonorrhoeae
– otitis media and sinusitis
– folliculitis, furuncle, furunculosis, carbuncle, erysipelas, cellulitis, lymphangitis(lymphadenitis), whitlow, purulent paronychia, subcutaneous abscess, hidradenitis, acne conglobate, and infectious atheroma
– prophylaxis of infection in case of contact with meningococcal meningitis patients
– pericoronitis and periodontitis